Despite this, AI-based technology is not yet being implemented or adopted at scale for day-to-day diabetes management, and awareness is limited amongst the clinical workforce, with the exception being the use of diabetes technology in type 1 diabetes (i.e. insulin pumps, glucose sensors and closed-loop systems). This evidence concerns the gene INS and type 1 diabetes mellitus.